Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
15 participants
INTERVENTIONAL
2025-02-03
2025-04-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the aim of this project is to study the impact of acute ingestion of casein glycomacropeptide supplemented with amino acids (cCGMP-AAs) alone or in combination with two different meals on amino acid absorption kinetics, glycaemic and insulinemic response, and on acute markers of appetite control.
The main findings of this project will bring new insights into the dietary management of these patients, which may lead to improvements in protein substitutes formulations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers
NCT05971563
Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU)
NCT05174559
Follow-up of Adult Phenylketonuria (PKU) Patients
NCT01096758
Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria
NCT06337864
High Protein and Exercise Therapy Plus Nocturnal Enteral Feeding in Juvenile-onset Pompe Disease
NCT01656590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meal A
Meal A - CGMP-AAs alone
cGMP-AAs alone (20 g of protein equivalent)
cGMP-AAs alone (20 g of protein equivalent)
Meal B
Meal B - CGMP-AAs in combination with carbohydrates (including fibre)
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
Meal C
Meal C - CGMP-AAs in combination with carbohydrates and fat
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cGMP-AAs alone (20 g of protein equivalent)
cGMP-AAs alone (20 g of protein equivalent)
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adults (age ≥ 18 years)
* Body Mass Index (BMI) between 18.5-25.0 kg/m2
* Filling informed consent
Exclusion Criteria
* Have changed frequency, duration, or intensity of physical activity in the last month
* Taking protein supplements
* Pregnant or breastfeeding
* Smoking and drug use
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Nova de Lisboa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NOVA Medical School|Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa,
Lisbon, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cGMP: Metabolism and Appetite
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.